Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Industry News

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

October 17, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2020

COBRA-REDUCE: Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy

Presenter: Robert A. Byrne

October 17, 2020

Presentation TCT 2020

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Presenter: Robert Byrne

October 17, 2020

Presentation TCT 2020

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

Presenter: Robert Byrne

October 15, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

Video

» Interview

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

October 17, 2020

Advertisement

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

COBRA-REDUCE: Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content